Autism Clinical Trial
Official title:
Treatment of Sleep Disturbances in Young Children With Autism
Verified date | January 2015 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This study will compare the efficacy of a behavioral parent training program (PT) aimed
specifically at common sleep disturbances compared to parent education (PE) program focusing
on general issues related to autism. In a sample of 40 well characterized young children who
meet criteria for an autism spectrum disorder (24-72 months), the investigators will test
whether the five session PT program is superior to the PE program in decreasing sleep
disturbances.
The primary aim of this study is to evaluate the efficacy and feasibility of a PT program
for sleep disturbance in young children with autism compared to PE.
To this end, there are two hypothesis:
- Hypothesis 1: After the end of treatment, PT will be significantly more effective than
PE in improving parent reports of a) bedtime struggles and resistance; b) sleep
latency; c) night wakings; d) morning wakings; and / or e) sleep association problems
as measured by the composite sleep index score from the modified Simonds and Parraga
Sleep Questionnaire (MSPSQ; Simond & Parraga, 1982; Wiggs & Stores, 1998).
- Hypothesis 2: At the end of treatment, children in the PT group (n=20) will display
significantly improved total sleep period as measured by actigraphy in comparison to
children in the PE group (n=20).
The secondary aim of this study is to evaluate the impact of participating in PT on child's
daytime behavior and functioning and parenting stress compared to PE.
To measure this aim, there are 4 exploratory hypothesis:
- Exploratory Hypothesis 1: Lower Irritability subscales scores will be reported on both
parent and teacher / therapist completed Aberrant Behavior Checklist (ABC) for the PT
group than the PE group at 4 weeks and 8 weeks
- Exploratory Hypothesis 2: Lower Child Behavior Checklist (CBCL; parent completed) and
Caregiver-Teacher Report Form (C-TRF; teacher completed) scores will be reported for
the PT group than the PE group at 4 weeks and 8 weeks.
- Exploratory Hypothesis 3: The PT group will have higher scores on the Vineland Adaptive
Behavior Scales: 2nd Edition (VABS-II) at 4 weeks and 8 weeks compared to PE group.
- Exploratory Hypothesis 4: Parents receiving PT will report significantly lower scores
on the Parenting Stress Index (PSI) at 4 weeks and 8 weeks compared to parents
receiving PE.
Status | Completed |
Enrollment | 40 |
Est. completion date | January 2013 |
Est. primary completion date | November 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 24 Months to 72 Months |
Eligibility |
Inclusion Criteria: - Diagnosed with an autism spectrum disorder - Presence of sleep disturbance Exclusion Criteria: - Medical etiology of sleep disturbance |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital of Pittsburgh Autism Cetner | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Modified Simond & Parraga Sleep Questionnaire (MSPSQ) - Composite Sleep Index | The MSPSQ used by Wiggs and colleagues (Wiggs & Stores, 1996 ; Wiggs & Stores, 1999 : Wiggs & Stores, 2004) was used to assess the child's sleep quality. It was completed by the primary caregiver for both groups at baseline and at weeks 4 and 8. Using Wiggs & Stores earlier-described conventions for determining the Composite Sleep Index (CSI) score, the CSI was calculated by assigning a score to the frequency of the targeted sleep problems: bedtime resistance, night awakening, early awakening, and sleeping in places other than bed. In addition, scores were assigned for the duration of sleep latency and night awakenings. The total CSI score ranged from 0 to 12, with higher scores indicating more severe bedtime and sleep patterns. | Baseline, Week 4, and Week 8 | No |
Primary | Actigraphy - Sleep Efficiency | Measure of sleep efficiency defined as the percentage of time sleeping while in bed with lights off | Baseline, Week 4, Week 8 | No |
Primary | Actigraphy - Sleep Latency | Measure of sleep latency defined by the time from lights off to sleep onset. | Baseline, Week 4, Week 8 | No |
Secondary | Actigraphy - Total Sleep Time | Measure of total time spent asleep using Motionlogger model actigraph by Ambulatory Monitoring, Inc. (www.ambulatory-monitoring.com) and algorithms in associated software. | Baseline, Week 4, Week 8 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|